Current Evidence on the Efficacy of Gluten-Free Diets in Multiple Sclerosis, Psoriasis, Type 1 Diabetes and Autoimmune Thyroid Diseases.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic search methodology
PubMed 32752175 · doi:10.3390/nu12082316
What was done
This narrative review summarized clinical data on the efficacy of a gluten-free diet and the prevalence of celiac disease and gluten-related antibodies in non-celiac patients with multiple sclerosis, psoriasis, type 1 diabetes, and autoimmune thyroid diseases.
What was found
The abstract reports no quantitative values or numbers. Adequately powered and controlled intervention trials are lacking. In multiple sclerosis, one trial reported significant results but had major methodological limitations. In psoriasis, a few publications observed benefits only in patients seropositive for anti-gliadin or deamidated gliadin antibodies, but not in seronegative patients. In type 1 diabetes, studies are contradictory, though a gluten-free diet may help normalize metabolic control without altering islet autoantibody levels. In non-celiac autoimmune thyroid diseases, the diet has not been studied, though thyroid-related antibodies responded in patients with concomitant celiac disease. Overall, evidence is insufficient to recommend a gluten-free diet to non-celiac patients with these conditions.
Why it matters
The review underscores that despite widespread interest, current clinical trial evidence does not support prescribing a gluten-free diet for managing non-celiac autoimmune diseases.
Limits
The underlying evidence base lacks adequately powered, properly controlled trials. Available studies have substantial methodological flaws, conflicting findings, or focus only on specific serological subgroups, and the abstract omits quantitative metrics.
Cited by
- partial Eating gluten triggers molecular mimicry and antibody attacks against the thyroid gland in individuals with Hashimoto's thyroiditis.